Acquisitions8 Jul 2026, 04:50 pm
Jagsonpal Pharma Completes 77.21% Stake Acquisition in Aequitas
AI Summary
Jagsonpal Pharmaceuticals Ltd has announced the completion of its acquisition of a 77.21% equity stake in Aequitas Healthcare Private Limited. This follows previous disclosures on June 29, 2026, and July 7, 2026, regarding the proposed acquisition. The company had initially aimed to acquire an 85% stake. This development signifies a significant step in Jagsonpal's strategic growth and expansion within the healthcare sector.
Key Highlights
- Jagsonpal Pharmaceuticals acquired 77.21% equity stake in Aequitas Healthcare.
- The acquisition is a partial fulfillment of the initially proposed 85% stake.
- This move is part of the company's strategic expansion plans.
- The transaction was previously disclosed on June 29 and July 7, 2026.
Price Impact
More from JAGSNPHARM